Instil Bio Announces Effective Date of 1-for-20 Reverse Stock Split

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/05/2791377/0/en/Instil-Bio-Announces-Effective-Date-of-1-for-20-Reverse-Stock-Split.html

DALLAS, Dec. 05, 2023 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil” or the “Company”) (NASDAQ:TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, today announced that a 1-for-20 reverse stock split of its outstanding shares of common stock will be effective as of 5:00 p.m. Eastern Time on Thursday, December 7, 2023.

Read more at globenewswire.com

Related news for (TIL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.